Mitochondria are double-membraned organelles with variable shapes influenced by metabolic conditions, developmental stage, and environmental stimuli [1] [2] [3] [4] . Their dynamic morphology is a result of regulated and balanced fusion and fission processes 5, 6 . Fusion is crucial for the health and physiological functions of mitochondria, including complementation of damaged mitochondrial DNAs and the maintenance of membrane potential [6] [7] [8] . Mitofusins are dynaminrelated GTPases that are essential for mitochondrial fusion 9, 10 . They are embedded in the mitochondrial outer membrane and thought to fuse adjacent mitochondria via combined oligomerization and GTP hydrolysis [11] [12] [13] . However, the molecular mechanisms of this process remain unknown. Here we present crystal structures of engineered human MFN1 containing the GTPase domain and a helical domain during different stages of GTP hydrolysis. The helical domain is composed of elements from widely dispersed sequence regions of MFN1 and resembles the 'neck' of the bacterial dynaminlike protein. The structures reveal unique features of its catalytic machinery and explain how GTP binding induces conformational changes to promote GTPase domain dimerization in the transition state. Disruption of GTPase domain dimerization abolishes the fusogenic activity of MFN1. Moreover, a conserved aspartate residue trigger was found to affect mitochondrial elongation in MFN1, probably through a GTP-loading-dependent domain rearrangement. Thus, we propose a mechanistic model for MFN1-mediated mitochondrial tethering, and our results shed light on the molecular basis of mitochondrial fusion and mitofusin-related human neuromuscular disorders 14 
H may be longer in full-length MFN1.
The overall topology of MFN1 IM is typical of the dynamin superfamily [15] [16] [17] [18] [19] [20] (Extended Data Fig. 4) . Apart from the G domain, the MFN1 IM HD1 is particularly consistent with the neck of the Nostoc punctiforme bacterial dynamin-like protein (BDLP), which was suggested to mediate membrane fusion in bacteria 21 (Extended Data Figs 2a, 4, 5a). Given the compact organization of HD1 and the predicted secondary structure (Extended Data Fig. 3 ), the missing portion of MFN1 (excluding the transmembrane domain) from MFN1 IM is likely to fold into a helix-rich domain resembling the 'trunk' and 'paddle' of BDLP 21 . We term this putative region helical domain 2 (HD2). 1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Crystallized constructs Full-length MFN1
When bound to tubulated liposomes in the presence of GMPPNP, BDLP bears G domain-neck and neck-trunk rearrangements via so-called hinge 2 and hinge 1 (ref. 22 ). Notably, Lys336 of MFN1 IM exactly overlaps with BDLP Arg327 at hinge 2b, whereas MFN1 IM Gly309 and Arg74 also have counterparts in BDLP (Gly309 in hinge 2b
and Gly68 in hinge 2a) at equivalent positions (Fig. 1e) . Mutation of these hinge-2-related residues diminished GTPase activity and mitochondrial elongation, although the G domain and HD1 exhibited only limited relative movement in different nucleotide-loading states (Extended Data Fig. 5b-e) . Similar to dynamins, the potential hinge 1 between HD1 and predicted HD2 (368-YSVEER-373 and 692-EEEIAR-697) lacks overall conservation among mitofusins (Extended Data Fig. 3) . A proline insertion in 692-EEEIAR-697 abolished mitochondrial elongation activity (Extended Data Fig. 5e, f) . Altogether, full-length MFN1 may undergo conformational changes similar to BDLP when mediating outer mitochondrial membrane (OMM) fusion via aforementioned hinges.
G1-G4 elements of GTPases are essential for binding and hydrolysis of GTP (Fig. 2a) . Notably, in the nucleotide-free (apo) MFN1 IM structure, the nucleotide-binding pocket is occupied by the bulky side chain of Trp239 from G4, a residue conserved only in mitofusins and BDLP (Fig. 2b) . Loading of GTP drives Trp239 away, causing it to wedge into a wide hydrophobic groove formed by Met249 from α 4 G and Phe282 from β 6 G . This rearrangement allows the suitable positioning of Asn237 and Asp240 to dock the guanine base (Fig. 2b) . Mutation of Trp239 to alanine abolished nucleotide-binding and GTPase activity of MFN1 IM (Fig. 2c, d ). Both MFN1(W239A) and the corresponding MFN2 mutant MFN2(W260A) were nonfunctional for mitochondrial elongation (Fig. 2e) , manifesting the importance of this tryptophan switch. When accommodating a nucleotide, MFN1 IM uses α 2' G to loosely buttress the guanine from a vertical orientation, and a large area of the nucleotide is thus exposed. This feature is shared by BDLP but not with dynamin-1 (refs 21,23) , in which the nucleotide is tightly wrapped (Extended Data Fig. 5g ).
Whereas the apo and GTP structures are monomeric, MFN1 IM forms a homodimer in the presence of the transition state mimic GDP•AlF 4 − (Extended Data Fig. 6a ). Dimerization is mediated by association of the G domains across the nucleotide-binding pocket, and the HD1s protrude in opposite directions from the dimer axis (Fig. 3a) . Major interactions of this 995 Å 2 'G interface' include a pair of symmetrical, parallel aligned salt bridges between Arg238 in the G4 element and Glu209 in the loop between β 3 G and α 3 G (Fig. 3b ). Flanking this central salt-bridge pair, close in trans contacts are also observed between Lys99-Glu245, His144-Glu247, and His147-Asp251. In addition, the side chain of Tyr248 inserts into the groove between switch I and α 1' G of the other molecule (Fig. 3b) . G domain dimerization has been found in several dynamin superfamily members in the transition state of GTP hydrolysis [23] [24] [25] . Compared to the approximately 2,500 Å 2 G interface of dynamin-1 (ref. 23) involving extensive hydrogen bonds and hydrophobic associations, the substantially smaller G interface of MFN1 IM is dictated by charged interactions, and no in trans stabilization of the nucleotides is observed (Fig. 3c) .
To verify the functional relevance of G-domain-mediated dimerization, we performed mutagenesis studies on residues Glu209 and Arg238. Whereas GDP•AlF 4 − induced the formation of MFN1 IM dimers in analytical gel filtration coupled to right angle light scattering (RALS) assays, MFN1 IM (E209A) and MFN1 IM (R238A) failed to dimerize (Fig. 3d) . Moreover, the two mutants lacked stimulated proteinconcentration-dependent GTPase activity (Fig. 3e) , even though they bound guanine nucleotides with wild-type affinity (Fig. 3f) . These results suggest that GTPase activation is mediated by dimerization via the G interface. In addition, MFN1 IM (E209A) and MFN1 IM (R238A) showed suppressed liposome tethering activity in vitro (Extended Data  Fig. 6b ). Both MFN1(E209A) and MFN1(R238A), as well as the corresponding MFN2 mutants MFN2(E230A) and MFN2(R259A), failed to elongate mitochondria (Fig. 3g) . Thus, G domain association of mitofusins during the transition state of GTP hydrolysis is an indispensable step for OMM fusion. In addition, mutations of most other residues involved in the G interface also impinge dimerization, GTP hydrolysis and mitochondrial elongation to various extents (Extended Data Fig. 6c-e) . 
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Nucleotide binding induces conformational changes in the residues defining the G dimer interface. In the nucleotide-free state, the conformation of MFN1 IM disfavours dimerization: Arg238 is blocked by the carbonyl oxygens of Ala241 and Ala243, whereas Glu209 and Glu245 are attracted by Arg253 (Extended Data Fig. 6f ). GTP-loadinginduced rearrangement of the G4 element translocates Trp239 to push Arg253 aside towards Glu316. As a result, Glu209, Glu245 and Arg238 are released and become solvent-facing, allowing for G domain dimerization.
During GTP hydrolysis, the conformationally flexible switch regions must be stabilized to favour catalysis. In our MFN1 IM structure solved from co-crystallization with GDP•AlF 4 − , although the AlF 4 − moiety is absent, the switch I holds a catalysis-compatible conformation analogous to those of other dynamin superfamily members in the transition state ( Fig. 4a and Extended Data Fig. 7a-d) . Notably, unlike many dynamin-related proteins, switch I of nucleotide-free MFN1 IM is fixed in a conformation distinct from that in the transition-like state by a hydrophobic network involving G2 element and α 1' G , indicating that switch I is rearranged through dimerization of the G domains (Figs. 2b, 3b and Extended Data Fig. 7a ).
Efficient GTP hydrolysis requires the neutralization of the negative charge developing between the β -and γ -phosphates in the transition state. A sodium ion coordinated by a QS motif in the P-loop takes over this role in dynamin-1 (ref. 23), whereas atlastin-1 possesses a cis-arginine finger in the P-loop 24 (Fig. 4a) . However, these motifs are not present in MFN1. Instead, a mitofusin-specific His107 in switch I stretches to the β -phosphate of GDP with a similar position as the charge-compensating ion/residue of dynamin-1 and atlastin-1. Furthermore, the side chain of His107 is coordinated by the carbonyl oxygen of Gly104, which corresponds to Gly60 of dynamin-1 and Gly114 of atlastin-1 (Figs 2a, 4a) . Mutation of His107 to alanine did not perturb the binding of guanine nucleotides but eliminated the GTPase activity of MFN1 IM (Fig. 4b, c) . Mfn1/2-null mouse embryonic fibroblasts (MEFs) transfected with either MFN1(H107A) or the corresponding mutant MFN2(H128A) were defective in mitochondrial elongation (Fig. 4d) . Thus, we propose this His107 finger as a charge-compensating factor during catalysis. The catalytic water responsible for the nucleophilic attack on the γ -phosphate was not observable, probably owing to the absence of the AlF 4 − moiety. Compared to other scission-related dynamin family members, MFN1 IM shows extraordinarily weak GTPase activity (Fig. 2d) . The stable conformation of switch I and the shielded GTP-binding pocket in the nucleotide-free state may account for this feature (Fig. 4e) . Slow GTP turnover, exemplified by BDLP 22 and EHD2 (ref. 15) , has been suggested to favour self-assembly over disassembly, and thus promote membrane fusion 26 . 
We also purified a near-full-length construct termed MFN1 ΔTM that contains the G domain, HD1 and HD2, but lacks the transmembrane domain (Extended Data Fig. 8a, b) . MFN1 ΔTM elutes as a stable dimer in RALS assays without nucleotide (Extended Data Fig. 8c ). This dimer, possibly mediated by HD2, may relate to the 180-kDa stable complex of rat MFN1 found in sedimentation studies 27 . Moreover, MFN1 ΔTM oligomerizes only when GDP•AlF 4 − is present (Extended Data Fig. 8d) , consistent with the previous observation that the 180-kDa MFN1 complex can form higher-order oligomers when incubated with GTP but not with GTPγ S 27 . MFN1 ΔTM with either Glu209Ala or Arg238Ala mutations failed to oligomerize (Extended Data Fig. 8e ), indicating that oligomerization is dependent on the G interface.
In the apo and GMPPNP-bound states, the neck and trunk of BDLP take either a 'closed' or 'open' conformation 21, 22 , and the contact between the G domain and the trunk may stabilize the former. Given the structural congruence with BDLP, MFN1 may also adopt this feature. A conserved Asp189 potentially participates in the plausible G-domain-HD2 contact (Fig. 4f) . This surface residue located on α 2 G is differently oriented between nucleotide-free and GTP-bound states, and in latter case its side chain swings away from the HD2 (Fig. 4g , Extended Data Fig. 8f, g ). MFN1(D189A) led to mitochondrial clumping (Extended Data Fig. 8h ).
Our data highlight the role of G domain dimerization, regulated by guanine nucleotide, in membrane fusion mediated by mitofusin. GTP loading may induce a conformational change from the closed tetheringconstrained state to the open tethering-permissive state, possibly involving the Asp189 trigger. In the open state, stretched MFN1 molecules allow efficient tethering of two OMMs with a distance of as far as 30 nm. During GTP hydrolysis, HD2 may fold back to the closed state to bring opposing membranes in close proximity (Extended Data Fig. 9a-c ). An analogous model based on the BDLP1 structure has been proposed 28 . This process may be reversible and controllable by local GTP concentration and MFN1 density, so that excessive tethering can be avoided.
A key issue to be resolved is the reconciliation of this model with the previous MFN1 tethering model, in which an antiparallel coiled coil summarizing the rearrangements in the G domain during GTP hydrolysis. G domains are coloured grey. Residues and nucleotides are colour/shapespecified. Salt bridges are specified by brown dots between involved residues. P i denotes phosphate ion. f, Superposition of nucleotide-free MFN1 IM B construct and BDLP (PDB code 2J69) with the predicted-HD2-facing Asp189 of MFN1 specified. g, Structural comparison of MFN1 IM in different nucleotide-loading states at α 2 G reveals distinct orientation of Asp189 in the GTP-bound state from other states. at the C terminus had a central role 13, 29 . One possibility is that MFN1 operates through sequential tethering events, an initial one using nucleotide-regulated, G domain dimerization followed by closer apposition via the coiled coil. For this sequence to happen, a large energy barrier must be overcome to detach α 4 H from the large hydrophobic network in HD1. It should also be noted that the G domain association of MFN1 may also occur in cis, as both forms have been proposed to have functions in BDLP 22 and atlastin-1 (ref. 30).
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No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment. Protein expression and purification. cDNAs of all truncated human MFN1 constructs, including those for crystallization and indicated mutants for biochemical assays were individually cloned into a modified pET28 vector. For constructs used in co-crystallization with GTP, an extra Thr109Ala mutation was introduced to the MFN1 IM C construct to suppress the GTPase activity. Details of these constructs are illustrated in Extended Data Fig. 1a . For MFN1 ΔTM , residues 580-631 were replaced by an (SAA) 5 linker. For MFN1 IM and corresponding mutants, recombinant proteins containing an N-terminal His 6 -tag followed by a cleavage site for PreScission protease (PSP) were expressed in Escherichia coli Rosetta (DE3) cells. Transformed bacteria were cultured at 37 °C before induced with 0.1 mM isopropyl-1-thio-β -d-galactopyranoside (IPTG) at an OD 600 nm of 0.6, and grown overnight at approximately 17-18 °C. Cells expressing MFN1 IM were lysed in 50 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 , 30 mM imidazole, 1 μ M DNase I, 1 mM phenylmethanesulfonylfluoride (PMSF) and 2.5 mM β -mercaptoethanol (β -ME) using a cell disruptor (JNBIO) and subjected to centrifugation at 40,000g for 1 h. The supernatant was filtered and applied to a Ni-NTA (first Ni-NTA) column (GE Healthcare) equilibrated with binding buffer 1 containing 20 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 , 30 mM imidazole and 2.5 mM β -ME. After washed with binding buffer 1, proteins were eluted with elution buffer containing 20 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 , 300 mM imidazole and 2.5 mM β -ME. Eluted proteins were incubated with 20 μ g glutathione S-transferase (GST)-fused PSP to remove the His 6 -tag and dialysed overnight against binding buffer 2 containing 20 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 and 2.5 mM β -ME. After dialysis, PSP was removed using a GST column.
The protein was re-applied to a second Ni-NTA column equilibrated with binding buffer 2. Binding buffer 1 was used to elute the proteins which were subsequently loaded onto a Superdex200 16/60 column (GE Healthcare) equilibrated with gel filtration buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 and 1 mM dithiothreitol (DTT). The proteins eluted in a discrete peak corresponding to a molecular mass of approximately 50 kDa. Cell lysis and protein purification were both performed at 4 °C. The selenomethionine (SeMet) derivative of MFN1 IM B was expressed in E. coli Rosetta (DE3) in M9 minimal media. For 1 l bacteria culture, 100 mg lysine, 100 mg phenylalanine, 100 mg threonine, 50 mg isoleucine, 50 mg leucine, 50 mg valine and 60 mg SeMet were added when OD 600 nm reached 0.5. The cells were then induced with 100 μ M IPTG and cultured at 18 °C for 24 h. Purification protocols for the SeMet derivative were the same as those of native protein. Mutants used in RALS, ITC and GTP hydrolysis assays were all based on MFN1 IM C, unless specified. Structure of MFN1 IM B in the nucleotide-free state (assigned PDB code 5GO4) was used in Fig. 1 are representative. Constructs based on MFN1 ΔTM each possess an extra Strep-tag that was inserted between the His 6 -tag and PSP cleavage site. Cells expressing MFN1 ΔTM (wild type or mutants) were collected and lysed in 50 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 , 30 mM imidazole, 1% Tween-20, 1 μ M DNase I, 1 mM PMSF and 2.5 mM β -ME with a cell disruptor (JNBIO). After centrifugation at 40,000g for 1 h, the supernatant was filtered and applied to a Ni-NTA column equilibrated with binding buffer 3 containing 20 mM HEPES, pH 7.5, 400 mM NaCl, 5 mM MgCl 2 , 30 mM imidazole, 1% Tween-20 and 2.5 mM β -ME. Proteins were eluted with elution buffer after washed with binding buffer 1 and reapplied to a StrepTactin column (GE Healthcare) equilibrated with binding buffer 2. Binding buffer 2 containing extra 2.5 mM desthiobiotin was used to elute the proteins. After the tags and PSP were removed in the same way as for MFN1 IM , proteins were applied to gel filtration using a Superdex200 16/60 column equilibrated with gel filtration buffer for GTPase assays or buffer containing 20 mM HEPES, pH 7.2, 30 mM NaCl, 5 mM MgCl 2 and 1 mM DTT for RALS assays. Protein crystallization. Purified MFN1 IM constructs were pre-incubated with corresponding nucleotides in tenfold concentration relative to protein for 2 h before being crystallized at 20 °C via hanging drop vapour diffusion by mixing equal volumes of protein (approximately 15-30 mg ml . Structural illustrations were prepared using the PyMOL Molecular Graphic Systems (version 0.99, Schrödinger LLC; http://www. pymol.org/). The 6.1 Å MFN1 IM A•GTPγ S structure and 4.3 Å MFN1 IM A•GDP structure were not further refined after molecular replacement. X-ray data collection and refinement statistics can be found in Extended Data Table 1 . The area of the G interface was calculated using the PISA server 40 . The Ramachandran statistics determined by PROCHECK 41 are as follows: 98.3% in favoured region, 1.7% allowed, 0 outlier for apo MFN1 IM B; 98.7% favoured, 1.0% allowed, 0.3% outlier for GTP-bound MFN1 IM C(T109A); 95.8% favoured, 4.1% allowed, 0.1% outlier for transition-like state MFN1 IM C and 98.0% favoured, 2.0% allowed, 0 outlier for GDP-bound MFN1 IM C(T109A). RALS. A coupled RALS-refractive index detector (Malvern) was connected in line to an analytical gel filtration column Superdex200 10/300 to determine absolute molecular masses of the applied protein samples. For each experiment, 100 μ M purified MFN1 IM C (wild type or mutants) or approximately 10-30 μ M MFN1 ΔTM (wild type or mutants) was incubated with or without 1 mM corresponding ligand for 6 h at 25 °C before the measurement. The column was equilibrated with 20 mM HEPES, pH 7.2, 30 mM NaCl, 5 mM MgCl 2 and 1 mM DTT. Data were analysed with the provided OMNISEC software. All experiments were repeated at least twice and the data showed satisfying consistency. GTP hydrolysis assay. GTP hydrolysis assays for MFN1 IM C, MFN1 ΔTM and corresponding mutants were carried out at 37 °C in 20 mM HEPES, pH 7.5, 150 mM NaCl, and 5 mM MgCl 2 and 1 mM DTT as described earlier 42 . For measuring stimulated GTP turnover of wild-type MFN1 IM C, MFN1 IM C(E209A), and MFN1 IM C(R238A), protein at concentrations of 0.5, 1, 2.5, 5, 10, 20 and 40 μ M were individually mixed with 1-2 mM GTP and hydrolysis rates were determined from a linear fit to the initial rate of the reaction (< 40% GTP hydrolysed). For other experiments, 20 μ M protein and 1 mM GTP were used. Nucleotide binding study. The equilibrium dissociation constants for MFN1 IM C and indicated mutants to guanine nucleotides were determined by isothermal titration calorimetry (ITC) using a MicroCal ITC200 (Malvern) at 25 °C. 2 mM nucleotide was titrated at 2 μ l step against 60-80 μ M protein in the buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 2.5 mM β -ME. Resulting heat changes upon each injection was integrated and the values were fitted to a standard single-site binding model using Origin7. All experiments were repeated at least twice and the data showed satisfying consistency. Mitochondrial elongation assay. To examine the effect of point mutations, MFN1-Myc and MFN2-Myc variants were expressed in Mfn1/2-null MEFs from the pQCXIP retroviral vector. MEFs were generated in-house. The cell line is free of myoplasma and has been authenticated by genotyping with PCR to confirm deletion of the Mfn1 and Mfn2 genes. Point mutants in mouse Mfn1 and Mfn2 were constructed by overlapping PCR with primers encoding the point mutation. All mutations were confirmed by DNA sequencing. The types and positions of the residues mutated in this study are all consistent between human and mouse mitofusins. Retroviral supernatants were produced from 293T cells transfected with the retroviral vector and the packaging plasmid pCLEco. Mfn1/2-null MEFs were maintained in DMEM supplemented with 10% fetal bovine serum and penicillin/streptomycin at 37 °C and 5% CO 2 . After retroviral transduction of Mfn1/2-null MEFs, puromycin selection was applied for 2 days. Cells were plated onto 8-well chambered slides for analysis. In the case of Mfn1 constructs, Mfn1/2-null cells stably expressing mito-DsRed were used; for Mfn2 constructs, Mfn1/2-null cells stably expressing mito-eGFP were used. Immunostaining and western blot analysis with the 9E10 antibody against Myc was performed to confirm localization and proper expression of the mitofusin variant. Mitochondrial morphology was scored by analysis of mito-DsRed or mito-GFP as described previously 12 .
letter reSeArCH Liposome tethering assay. POPC (1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine), DOPS (1,2-dioleyl-sn-glycero-3-phospho-l-serine), DOGS-NTA-Ni
2+
(1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid) succinyl] (nickel salt)) and Rho-DPPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)) (Avanti Polar Lipids) were mixed in a molar ratio of 78.5:15:5:1.5. Lipid film formed by evaporating chloroform under mild nitrogen stream was dehydrated in a vacuum drier before being re-suspended in buffer L (20 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM β -ME) to a final concentration of 10 mM. Liposomes were prepared as previously described 30 . An internal His 12 tag was inserted between α 3 H and α 4 H of MFN1 IM C and corresponding mutants. For each reaction, 0.5 μ M protein was mixed with 1 mM prepared liposomes in buffer L for 30 min at 4 °C before 5 mM GTP or GTPγ S was subsequently added. After incubation for another 40 min at 37 °C, the proteoliposomes were imaged by a fluorescent microscope. Otherwise, the proteoliposomes were incubated with 300 mM imidazole, pH 7.5, for another 20 min to release the protein and then imaged. All experiments were repeated at least twice and the data showed satisfying consistency. Data availability. The X-ray crystallographic coordinates and structure factor files for MFN1 IM structures have been deposited in the Protein Data Bank (PDB) under the following accession numbers: 5GO4 (apo MFN IM B), 5GOF (GTP-bound MFN1 IM C(T109A)), 5GOM (transition-like state MFN1 IM C), and 5GOE (GDPbound MFN1 IM C(T109A)). All other data generated or analysed during this study are included in this published article, and are available from the corresponding author upon reasonable request. β5  β6  β4  β3  β1  β2   G2   G3  G4   G1   H5  H10   H11   H3  H9   H7  H8   H12  C   β1'  β2'  β5  β6  β4  β3  β1  β2   G2   G3  G4   G1   H4   H6 α1' Sequence alignment of mitofusins and BDLP. Amino acid sequences of human (hs) MFN1 (UniProt accession Q8IWA4) and MFN2 (O95140), mouse (mm) MFN1 (Q811U4) and MFN2 (Q80U63), fruitfly (Drosophila melanogaster, dm) Marf (Q7YU24), fruitfly Fzo (O18412) and BDLP from N. punctiforme (B2IZD3) are aligned using Clustal W 43 . Residues with a conservation of 100% are in red shades, greater than 80% in green shades and 50% in grey shades, respectively. α -helices are shown as cylinders and β -strands as arrows for both nucleotide-free human MFN1 (above the sequences) and nucleotide-free BDLP (2J, under the sequences). In the case of human MFN1, the secondary structure signs are coloured as in Fig. 1b and labelled as in Fig. 1b-d for MFN1 IM regions. Secondary structural elements of the missing HD2 and transmembrane domain predicted from the PHYRE2 server 44 (exclusively α -helices) are depicted as shaded cylinders with dashed outlines. For BDLP, the secondary structure signs are coloured grey and labelled according to the previous report 21 . The G1-G4 elements are specified in the sequences. Key residues on human MFN1 are also indicated, including those involved in the hydrophobic core of HD1 (diamond symbol), hinges (downwards triangle), guanine nucleotide binding and hydrolysis (circle), G interface (upwards triangle), and the plausible HD1-HD2 conformational change (square). − -bound states. Note that in the GDP•AlF 4 − -bound state, no peak at the exclusion volume is observed, indicating that both mutants do not oligomerize. f, Structural comparison of MFN1 IM in different nucleotide-loading states at α 2 G . Note the distinct orientation of Asp189 in the GTP-bound state, and the uniformly oriented Asp193. Asp193 is a conserved residue that also faces the predicted HD2. Colour as in Fig. 4g . g, Electron density of Asp189 and Asp193 on α 2 G in MFN1 IM structures contoured at 1.0σ. Note the difference in orientations of α 2 G in these structures as revealed by the density maps. Although the side chain of Asp189 is not fully traceable in some non-GTP-bound cases, their locations would differ from that in the GTP-bound form. h, Mitochondrial elongation assay for the mutants in the plausible G-domain-HD2 contact. For each construct, 100 cells were scored in biological triplicate; representative images are shown. Error bars indicate s.e.m. Scale bars, 10 μ m. Note that the clumping mitochondria for MFN1(D189A) and anticipated normal mitochondria for MFN1(D193A). Arg455, Arg460, Gln473 and Arg594 are conserved residues in the predicted HD2 which were screened for contacting Asp189 based on sequence alignment of mitofusins and BDLP. Corresponding mutants increased mitochondrial fragmentation or aggregation. It seems that either they are not the right residues interacting with D189, or a single point mutation was not sufficient to break the plausible interaction.
